Latest Leadership Transitions News

Page 1 of 87
Sparc Technologies has appointed former Micro-X chief executive Kingsley Hall to lead its graphene additives and green hydrogen businesses into their next commercial phase. The transition gives Hall an immediate mandate to grow ecosparc sales and advance Sparc Hydrogen beyond pilot operations, while his incentive package ties part of his reward to shareholder returns and revenue milestones.
Sophie Babbage
Sophie Babbage
19 Nov 2026
Northern Star says KCGM commissioning is improving but remains beset by interruptions, with November availability at 72% and throughput up 15%. The update also puts the company’s rejected Gold Fields approach back in focus as new chief executive Suresh Vadnagra promises tighter operational and capital discipline.
Maxwell Dee
Maxwell Dee
18 Nov 2026
Webjet Group has swung to a $2.7 million statutory half-year loss after weaker online travel bookings, lower revenue margins and airline commission changes cut underlying EBITDA by 51%. New CEO Nicole Sheffield is targeting $10 million in annualised savings, but restructuring costs and further pressure from credit card surcharging reforms are still ahead.
Victor Sage
Victor Sage
18 Nov 2026
NVIDIA delivered record fiscal third-quarter revenue of US$115.8 billion, with Data Center sales rising 110% year on year. The company expects another record quarter, but its outlook excludes China compute revenue and comes alongside US$518 billion of commitments and up to US$118 billion of guarantee exposure.
Sophie Babbage
Sophie Babbage
18 Nov 2026
GrainCorp has swung to a $10.1 million statutory loss after weak grain margins cut earnings, while the board begins searching for CEO Robert Spurway’s successor. The company expects export and crush margins to improve in FY27, but its transformation program remains unfinished and cash has fallen sharply.
Victor Sage
Victor Sage
12 Nov 2026
PMET Resources has upgraded the economics of its Shaakichiuwaanaan lithium-tantalum project, cutting projected life-of-mine AISC by 18% while lifting after-tax NPV to approximately CA$5.1 billion. The company is also searching internationally for a new CEO as Ken Brinsden prepares to move into an executive chair role in 2027.
Maxwell Dee
Maxwell Dee
11 Nov 2026
Biotron CEO and executive director Glenn Gilbert has started more than two months ahead of schedule, immediately taking charge of a strategic review centred on SedRx. The review will also test development priorities, capital allocation and partnering options across the company’s drug portfolio.
Ada Torres
Ada Torres
9 Nov 2026
Ansell has entered FY27 with stronger margins, cash generation and shareholder distributions after adjusted EBIT rose 14.9% organically in FY26. The PPE maker is maintaining adjusted EPS guidance of 158 to 170 US cents while targeting further growth from US markets, productivity and a simpler product range.
Victor Sage
Victor Sage
9 Nov 2026
PNC has named retail banking chief Alexander Overstrom as its next chief financial officer, with the handover scheduled for March 2027. Current CFO Robert Reilly will remain with the bank as executive vice chairman, preserving senior leadership continuity.
Victor Sage
Victor Sage
6 Nov 2026
WhiteHawk reported a US$313,000 operating cash outflow for the September quarter, while a new A$1.5 million debt facility and A$1.24 million in annualised cost savings support its next phase. The post-quarter completion of Quixxi adds AI governance products, international customers and a four-year A$635,238 Italian contract, but revenue conversion remains the test.
Victor Sage
Victor Sage
30 Oct 2026
Canyon Resources has withdrawn its target for a first bauxite shipment in Q4 2026 after AFG Bank suspended further drawdowns on its Cameroon project facility. Rail and road infrastructure advanced, but port dredging, transhipping and a broader funding review now stand between the project and operations.
Maxwell Dee
Maxwell Dee
30 Oct 2026
Imugene reported an 86% overall response rate in its BTK inhibitor combination cohort, but ended September with only 0.70 quarters of estimated funding at the reported cash burn. The biotechnology company is assessing further capital sources while navigating a leadership transition and convertible note obligations.
Ada Torres
Ada Torres
30 Oct 2026

Browse the archive

Full archive